Abbott and Novo Nordisk to provide integrated digital solution to people with diabetes using insulin
ABBOTT PARK, Ill. —Abbott and Novo Nordisk announced Wednesday a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The partnership reflects both companies′ commitment to make diabetes